Source / episode info

• **Episode:**343
• **Title:**Divine Intervention Episode 343 – Paraneoplastic Syndromes and The USMLEs (Step 1-3)
• **Published:**2021-09-29
• Source:Episode page

One-liner

This episode provides a high-yield review of classic paraneoplastic syndromes, covering endocrine (SIADH, PTHrP hypercalcemia), neuromuscular (Myasthenia gravis/Thymoma, Anti-Jo-1 myositis), and CNS manifestations (Limbic Encephalitis, PCD) associated with various malignancies.

High-yield summary

• Small Cell Lung Cancer (SCLC): Classically associated with Syndrome of Inappropriate ADH secretion (SIADH) leading to hyponatremia and concentrated urine (>1.012 SG). It can also cause ACTH excess, leading to Cushingoid features.
• Hypercalcemia Syndromes: PTHrP production (often from Squamous Cell Lung Cancer) causes hypercalcemia; Multiple Myeloma causes it via IL-6/osteoclast activation. Both require differentiation based on associated findings and PTH levels.
• Neuromuscular Junction: Thymomas are the most common cause of paraneoplastic Myasthenia Gravis, often presenting with signs of Superior Vena Cava (SVC) syndrome.
• CNS Paraneoplastics: Anti-Yo antibodies are strongly associated with Paraneoplastic Cerebellar Degeneration (PCD). Limbic Encephalitis can be linked to SCLC (Anti-Hu) or Germ Cell Tumors (Anti-Ma2), presenting with fever, headache, and neuropsychiatric symptoms.
• Specific Syndromes: Glucagonoma causes Necrolytic Migratory Erythema (NME); Carcinoid syndrome involves flushing, diarrhea, and cardiac valvulitis due to serotonin excess; Sweet Syndrome presents with tender neutrophilic skin lesions in the context of hematologic malignancy.

Learning objectives

• Differentiate between various paraneoplastic syndromes based on associated malignancies and specific biomarkers/antibodies.
• Understand the pathophysiology of SIADH, PTHrP hypercalcemia, and other endocrine paraneoplastics.
• Recognize the clinical presentation and diagnostic workup for neuromuscular (MG) and CNS (Limbic Encephalitis, PCD) paraneoplastic processes.
• Correlate specific skin findings (e.g., NME, Canthorasis Migratoria) with underlying GI or endocrine malignancies.
• Master the differential diagnosis of hypercalcemia in malignancy (PTHrP vs Multiple Myeloma).

Board exam buzzwords